Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9bc58bd7b2c4128df68b3b2f18799e08 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-101 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-572 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
filingDate |
2019-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_004c9eae9f9d509e6b9f970a81145749 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2d67cc8a2116864137d176514e55182 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36a6e1654c31269f575fd2725c9de435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffa820324cf6ad045a2162a529acb808 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de4122caaf8d972cdb6d73a45811015d |
publicationDate |
2019-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2019080574-A |
titleOfInvention |
Compositions and methods for treating type 1 diabetes |
abstract |
The present invention provides compositions and methods for treating insulin dependent diabetes. SOLUTION: A self vector which is 95% or more identical to a nucleic acid sequence of a self vector (BHT-3021) encoding and expressing human proinsulin (hINS), and an endotoxin free adjuvant as a pharmaceutically acceptable carrier. The present invention provides a composition comprising a self vector and a method for treating or preventing insulin-dependent diabetes comprising administering the self vector intramuscularly. [Selected figure] Figure 1 |
priorityDate |
2013-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |